about
Targeting adenosine in cancer immunotherapy: a review of recent progress.Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A2A blockade enhances anti-metastatic immune responses.
@en
A2A blockade enhances anti-metastatic immune responses.
@nl
type
label
A2A blockade enhances anti-metastatic immune responses.
@en
A2A blockade enhances anti-metastatic immune responses.
@nl
prefLabel
A2A blockade enhances anti-metastatic immune responses.
@en
A2A blockade enhances anti-metastatic immune responses.
@nl
P2093
P2860
P356
P1433
P1476
A2A blockade enhances anti-metastatic immune responses.
@en
P2093
John Stagg
Nicole Milenkovski
Paul A Beavis
P2860
P304
P356
10.4161/ONCI.26705
P577
2013-10-22T00:00:00Z